Single and dual doping effects of B and Fe on ZnO nanoparticles: from defect modulation to anticancer selectivity
Applied Physics A: Materials Science and Processing, cilt.132, sa.11, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 132 Sayı: 11
- Basım Tarihi: 2026
- Doi Numarası: 10.1007/s00339-026-10424-5
- Dergi Adı: Applied Physics A: Materials Science and Processing
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Aerospace Database, Chemical Abstracts Core, Chimica, Compendex, INSPEC, Academic Search Ultimate (EBSCO), Engineering Source (EBSCO), Materials Science & Engineering Collection (ProQuest), Technology Collection (ProQuest)
- Anahtar Kelimeler: B-doped ZnO, Co-precipitation method, Defect-related electronic structure, Fe-B co-doping, Intracellular ROS, Selectivity index
- İstanbul Üniversitesi Adresli: Evet
Özet
This study investigates the structural, optical, and anticancer properties of undoped ZnO, 5% Fe-doped ZnO, 5% B-doped ZnO, and 5% Fe–5% B co-doped ZnO nanoparticles synthesized via a co-precipitation method. Comprehensive characterization was performed using XRD, SEM, EDS, UV–Vis, and PL spectroscopy, together with biological evaluation by MTT and intracellular ROS assays using A549 lung adenocarcinoma and BEAS-2B normal bronchial epithelial cells. XRD confirmed that all samples retained a single-phase polycrystalline wurtzite ZnO structure. Fe–B co-doping reduced the crystallite size from 29.9 to 10.4 nm while increasing the lattice strain from 1.12 × 10⁻3 to 2.72 × 10⁻3, the internal stress from 133 to 344 MPa, and the strain energy density from 80 to 480 kJm⁻3. SEM analysis revealed that B doping suppressed particle growth to produce homogeneous nanoparticles (20–70 nm with an average size of 41.35 nm). In contrast, Fe doping promoted extensive interparticle aggregation despite its smaller crystallite size (11.6 nm). Fe incorporation narrowed the optical band gap from 3.50 to 2.97 eV, whereas the Fe–B co-doped sample exhibited the highest Urbach energy (0.322 eV), indicating the greatest structural disorder. On the other hand, B doping produced a balanced electronic structure with a band gap of 3.36 eV and a moderate Urbach energy (0.237 eV). PL spectra further supported the enhanced defect-related optical disorder in Fe-containing samples through quenched near-band-edge emission and intensified deep-level recombination. Among all formulations, B-doped ZnO exhibited the highest anticancer activity, with the lowest IC50 value (38.67 μg mL⁻1) and the highest selectivity index (SI = 2.07). Intracellular ROS analysis using the H2DCFDA assay revealed that B-doped ZnO did not significantly increase ROS levels despite its superior anticancer selectivity, suggesting that its biological activity is not predominantly governed by an ROS-mediated mechanism. Overall, the results demonstrate that although Fe incorporation and Fe–B co-doping induce more pronounced structural and optical changes associated with defect states, boron incorporation produces a more favorable physicochemical environment for selective anticancer activity, thereby revealing a clear relationship between the material characteristics and biological response of ZnO nanoparticles.